Although studies have shown that FGFR1 can modulate the AKT/S OX2 and Scr/NF-κB pathways affecting PC progression, the upstream regulators of FGFR1 remain unclear (16, 34, 35). This evidence concerns the gene CD200 and pachyonychia congenita.